Fei Dong is an experienced biotechnology professional with expertise in bioassays, cell and gene therapy, and pharmacology. They completed a Ph.D. in Physiology at Xiamen University and a Bachelor's degree in Pharmacy at Ocean University of China. Fei's notable past roles include Postdoctoral Researcher at the University of Cincinnati, where they developed AAV-CRISPR mediated gene therapies, and Research Scientist I at Takeda, focusing on AAV platform development for gene therapies. Currently, Fei serves as a Sr. Advisor at Eli Lilly and Company, following a brief tenure as a Sr. Scientist at Sigilon Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices